Manufacture of clinical grade epstein-barr virus vaccine
Active Awarded Last action
- Contract number
- 75N91025F00001
- Awardee
-
Mriglobal UEI HKQHNFKNKL15
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,460,074
Award facts
- Opportunity
-
- EBV202501 Solicitation number
- Contract value 100% obligated
- $3,460,074.00 Current and potential, with all options
- Completion date 54% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Kansas City, MO 64110, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $3,460,074 |
About this award
The National Cancer Institute issued a delivery order to Mriglobal (doing business as Midwest Research Institute) on September 22, 2025, with a ceiling value of $3.46 million for manufacture of clinical-grade Epstein-Barr virus vaccine. Work is performed in Kansas City, MO, with ultimate completion by September 21, 2027, under firm fixed-price terms.
Mriglobal is a 501(c)(3) not-for-profit research organization specializing in vaccine development, pharmaceutical manufacturing, and medical countermeasure support for federal agencies. The organization operates sophisticated laboratory facilities supporting biosafety testing, infectious disease research, and clinical-grade vaccine production across the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Defense.
Quick answers
Who was awarded contract 75N91025F00001?
75N91025F00001 was awarded to Mriglobal by National Cancer Institute (National Institutes of Health) on September 22, 2025.
How much is contract 75N91025F00001 worth?
The government has obligated $3,460,074 on 75N91025F00001.
Is contract 75N91025F00001 an order under another contract?
Yes. 75N91025F00001 is a delivery order under 75N91023D00010, an indefinite delivery contract.
Was contract 75N91025F00001 competed?
The extent of competition for 75N91025F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award